AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. ADCT
  4. [EFFECT] ADC Therapeutics SA SEC Filing

[EFFECT] ADC Therapeutics SA SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 9, 2025 4:00 P.M.
Form: S-3
CIK: 0001771910
Company Name: ADC Therapeutics SA
File Number: 333-288437

Source:

Stock ADCT logo
Adc Therapeutics Sa

NYSE:ADCT

ADCT Rankings

#3705 Ranked by Market Cap
N/A Ranked by Dividends

ADCT Latest News

Aug 12, 2025
ADC Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update
Aug 5, 2025
ADC Therapeutics to Host Second Quarter 2025 Financial Results Conference Call on August 12, 2025
Aug 1, 2025
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
Jul 1, 2025
ADC Therapeutics Makes Grant to New Employee Under Inducement Plan
Jun 16, 2025
ADC Therapeutics Announces Updated ZYNLONTA® Investigator-Initiated Trial Data in R/R Marginal Zone Lymphoma Presented at 18th International Conference on Malignant Lymphoma (ICML)

ADCT Latest SEC Filings

Aug 12, 2025
[S-8] ADC Therapeutics SA Employee Benefit Plan Registration
Aug 12, 2025
[10-Q] ADC Therapeutics SA Quarterly Earnings Report
Aug 12, 2025
[8-K] ADC Therapeutics SA Reports Material Event
Jul 10, 2025
[424B3] ADC Therapeutics SA Prospectus Filed Pursuant to Rule 424(b)(3)
Jun 30, 2025
[S-3] ADC Therapeutics SA Shelf Registration Statement

ADCT Stock Data

300.86M
71.77M
21.58%
66.92%
4.87%
Biotechnology
Pharmaceutical Preparations
Switzerland
EPALINGES